Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge. (2015)
Attributed to:
Molecular and reverse genetics studies of orbivirus transmission host responses epidemiology and diagnostic systems
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2015.01.009
PubMed Identifier: 25643968
Publication URI: http://europepmc.org/abstract/MED/25643968
Type: Journal Article/Review
Volume: 116
Parent Publication: Antiviral research
ISSN: 0166-3542